全球In Silico药物发现市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，In Silico药物发现市场规模将从 2025 年的 42.1 亿美元成长至 166.4 亿美元，2026 年至 2034 年的复合年增长率为 16.51%。

随着製药公司积极采用计算方法来加速药物研发进程，全球In Silico药物发现市场正迅速发展。In Silico辅助药物发现技术利用电脑模拟、人工智慧和先进演算法来识别潜在的候选药物并预测其生物学行为。这种方法显着降低了传统实验室药物发现过程所需的时间和成本。

成长要素之一是对更快、更有效率的药物研发的需求日益增长，尤其是在应对新兴疾病和复杂病理方面。製药和生物技术公司正在将人工智慧 (AI) 和机器学习融入药物研发流程，以提高准确性和效率。此外，对生物资讯学和计算生物学投入的增加也进一步巩固了市场地位。

随着数位技术不断变革药物研发，In Silico药物发现市场预计将持续成长。巨量资料分析和云端运算在药物发现领域的日益普及将提升预测建模能力。医疗保健产业正寻求创新解决方案以加速治疗方法的研发，因此In Silico方法的应用有望显着增加。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球In Silico药物发现市场：按组成部分划分

• 市场分析、洞察与预测
• 软体
• 服务

第五章：全球In Silico药物发现市场：按应用领域划分

• 市场分析、洞察与预测
• 标靶分子的鑑定
• 目标检验
• 发现铅
• 先导药物最适化
• 临床前试验
• 其他的

第六章：全球In Silico药物发现市场：依最终使用者划分

• 市场分析、洞察与预测
• 製药公司
• 生技公司
• 受託研究机构
• 学术研究机构
• 其他的

第七章 全球In Silico药物发现市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • SchrA¶Dinger Inc
  • Certara USA Inc
  • Charles River Laboratories International Inc
  • Evotec SE
  • BenevolentAI
  • Exscientia
  • Insilico Medicine
  • Atomwise Inc
  • Molecular Partners AG
  • Relay Therapeutics
  • XtalPi Inc
  • Numerate Inc

The In-Silico Drug Discovery Market size is expected to reach USD 16.64 Billion in 2034 from USD 4.21 Billion (2025) growing at a CAGR of 16.51% during 2026-2034.

The Global In-Silico Drug Discovery Market is rapidly gaining momentum as pharmaceutical companies increasingly adopt computational methods to accelerate drug development. In-silico technologies use computer simulations, artificial intelligence, and advanced algorithms to identify potential drug candidates and predict their biological behavior. This approach significantly reduces the time and cost associated with traditional laboratory-based drug discovery processes.

One of the major growth drivers is the rising demand for faster and more efficient drug development, particularly in response to emerging diseases and complex medical conditions. Pharmaceutical and biotechnology companies are integrating artificial intelligence and machine learning into drug discovery workflows to enhance accuracy and efficiency. Additionally, increasing investments in bioinformatics and computational biology are further strengthening the market.

Looking ahead, the in-silico drug discovery market is expected to expand as digital technologies continue to transform pharmaceutical research. The growing use of big data analytics and cloud computing in drug development will enhance predictive modeling capabilities. As the healthcare industry seeks innovative solutions to accelerate therapeutic discoveries, the adoption of in-silico methods is likely to increase significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Software
• Services

By Application

• Target Identification
• Target Validation
• Lead Discovery
• Lead Optimization
• Preclinical Testing
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

COMPANIES PROFILED

• Schrdinger Inc, Certara USA Inc, Charles River Laboratories International Inc, Evotec SE, BenevolentAI, Exscientia, Insilico Medicine, Atomwise Inc, Molecular Partners AG, Relay Therapeutics, XtalPi Inc, Numerate Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Target Identification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Target Validation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lead Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Lead Optimization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Preclinical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-SILICO DRUG DISCOVERY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IN-SILICO DRUG DISCOVERY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 SchrA¶Dinger Inc
  • 9.2.2 Certara USA Inc
  • 9.2.3 Charles River Laboratories International Inc
  • 9.2.4 Evotec SE
  • 9.2.5 BenevolentAI
  • 9.2.6 Exscientia
  • 9.2.7 Insilico Medicine
  • 9.2.8 Atomwise Inc
  • 9.2.9 Molecular Partners AG
  • 9.2.10 Relay Therapeutics
  • 9.2.11 XtalPi Inc
  • 9.2.12 Numerate Inc